1 year return (CAGR)
24.37%
Brainstorm Cell Therapeutics Inc Exchange (NASDAQ, USD)
BCLI
0.87
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-60.82%
5 year return (CAGR)
-54.99%
10 year return (CAGR)
-31.11%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
9.60M
Price/Sales
10.90
Ent value
21.96M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-41.32%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.87 |
| Daily high | 0.87 |
| Daily low | 0.87 |
| Daily Volume | 1K |
| All-time high | 776.25 |
| 1y analyst estimate | 17.00 |
| Beta | 0.23 |
| EPS (TTM) | -0.95 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BCLI | S&P500 | |
| Current price drop from All-time high | -99.89% | -0.58% |
| Highest price drop | -99.94% | -56.47% |
| Date of highest drop | 17 Feb 2026 | 9 Mar 2009 |
| Avg drop from high | -89.72% | -10.68% |
| Avg time to new high | 145 days | 12 days |
| Max time to new high | 5381 days | 1805 days |
News
